Chen, Allen M <br/><br/>
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.  [electronic resource] 

 -  The Lancet. Oncology  06 2017 
 - 803-811 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(17)30246-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemoradiotherapy--adverse effects<br/>Deglutition Disorders--etiology<br/>Disease-Free Survival<br/>Follow-Up Studies<br/>Human papillomavirus 16<br/>Humans<br/>Induction Chemotherapy--adverse effects<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged<br/>Mucositis--etiology<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--diagnosis<br/>Neoplasm Staging<br/>Neutropenia--chemically induced<br/>Oropharyngeal Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Papillomavirus Infections--complications<br/>Radiotherapy Dosage<br/>Response Evaluation Criteria in Solid Tumors<br/>Survival Rate